NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors
暂无分享,去创建一个
A. Chen | K. Schalper | J. Eder | S. Boerner | M. Pilat | M. Cecchini | Wei Wei | P. LoRusso | Navid Hafez | Zenta Walther | Diane E Durecki | D. Durecki